Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

Transcriptional expression of ZICs as an independent indicator of survival in gliomas

Frontiers A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology

REST was significantly up-regulated in glioma. (A) The difference

Cancers, Free Full-Text

Frontiers Tissue and circulating biomarkers of benefit to immunotherapy in extensive-stage small cell lung cancer patients

Protein structure of REST, REST1, REST4 and REST5. REST contains the

REST regulates oncogenic properties of glioblastoma stem cells

Systematic analysis identifies REST as an oncogenic and immunological biomarker in glioma

The impact of mutational clonality in predicting the response to immune checkpoint inhibitors in advanced urothelial cancer

Gene expression clustering and the separation between IDH-MUT and

CD4 Polyclonal Antibody (19068-1-AP)

Expression microarray of HDAC family across varieties of cancers